Epclusa 400mg/100mg Tablets / Film-coated

Velpatasvir, sofosbuvir
"400mg, 100mg"
GILEAD SCIENCES INTERNATIONAL LTD.
Pack size 28's HDPE Bottle
Dispensing mode POM
Source UK
AgentModern Pharmaceutical Co.
Retail Price 84714.50 AED

Indications

Epclusa 400mg/100mg Tablets / Film-coated is used for: VELPATASVIR
Used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
SOFOSBUVIR
Sofosbuvir is used in combination therapy to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptype 1,2,3, or 4, and to treat HCV and HIV co-infected patients. The combination therapy includes either ribavirin alone or ribavirin and peg-interferon alfa.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Velpatasvir, sofosbuvir :

Mechanism of Action

SOFOSBUVIR
Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B polymerase. Sofosbuvir prevents HCV viral replication by binding to the two Mg2+ ions present in HCV NS5B polymerase's GDD active site motif.

Note

Epclusa 400mg/100mg "400mg, 100mg" Tablets / Film-coated manufactured by GILEAD SCIENCES INTERNATIONAL LTD. . Its generic name is Velpatasvir, sofosbuvir. Epclusa 400mg/100mg is availble in United Arab Emirates. Farmaco UAE drug index information on Epclusa 400mg/100mg Tablets / Film-coated is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Velpatasvir, sofosbuvir :